Low-Density Lipoprotein Particle Concentration and Size as Determined by Nuclear Magnetic Resonance Spectroscopy as Predictors of Cardiovascular Disease in Women
Top Cited Papers
Open Access
- 8 October 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (15) , 1930-1937
- https://doi.org/10.1161/01.cir.0000033222.75187.b9
Abstract
Background— Nuclear magnetic resonance (NMR) offers an alternative, spectroscopic means of quantifying LDL and of measuring LDL particle size.Keywords
This publication has 23 references indexed in Scilit:
- Relations of lipoprotein subclass levels and low-density lipoprotein size to progression of coronary artery disease in the pravastatin limitation of atherosclerosis in the coronary arteries (PLAC-I) trialThe American Journal of Cardiology, 2002
- Low-Density Lipoprotein Size, Pravastatin Treatment, and Coronary EventsJAMA, 2001
- Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemiaThe American Journal of Cardiology, 2001
- Low density lipoprotein particle size and risk of early-onset myocardial infarction in women.American Journal of Epidemiology, 2001
- Oral 17β-estradiol and medroxyprogesterone acetate therapy in postmenopausal women increases HDL particle sizeAtherosclerosis, 2001
- C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in WomenNew England Journal of Medicine, 2000
- The total apolipoprotein B/LDL-cholesterol ratio does not predict LDL particle sizeClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Apolipoproteins and ischaemic heart disease: implications for screeningThe Lancet, 1994
- Variability in cholesterol content and physical properties of lipoproteins containing apolipoprotein B-100Atherosclerosis, 1993
- A Prospective Study of Cholesterol, Apolipoproteins, and the Risk of Myocardial InfarctionNew England Journal of Medicine, 1991